Associations for Health Professionals
This page lists 56 references in the Main Healthy Skepticism Library relevant to Associations for Health Professionals.
Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.
HSL5482
Brettingham M.
Department of Health ends contract with drugs bulletin.
BMJ 2006 May 13;332(7550):1109
http://bmj.bmjjournals.com/cgi/content/extract/332/7550/1109-a
HSL5771
Harvie J.
Rebels with a cause: The constant campaigner
Australian Doctor 2006 Mar 31:20
HSL6895
Gillies R, Von Schon-Angerer, Hoen E.
Historic opportunity for WHO to re-assert leadership
The Lancet 2006;368:1405-1406
http://www.thelancet.com/
HSL5263
Lurie P, Tran T, Wolfe SM, Goodman R.
Violations of exhibiting and FDA rules at an American Psychiatric Association annual meeting.
J Public Health Policy 2005 Dec;26(4):389-99
HSL1916
Rowland C.
Doctors fight over drug firm influence: Some in hypertension society hit fees paid to members for talks
The Boston Globe 2005 Jun 16
HSL2817
Grup d'Etica Societat Catalana de Medicina Familiar i Comunitaria.
[Ethics in drug industry relations.
Opinions poll of family physicians in Catalonia]Aten Primaria 2004 Jun 15;34(1):6-12
Link to source with long URL
HSL6024
Mansfield PR.
Free offer for all BMJ readers from Healthy Skepticism
BMJ 2003 May 30;326
http://bmj.bmjjournals.com/cgi/eletters/326/7400/1205
HSL2236
Motchane JL.
Health for all or riches for some: WHO's responsible?
Int J Health Serv 2003;33(2):395-400
HSL2858
Health ACTION.
European Parliament soundly rejects move towards direct-to-consumer advertising. HAI Europe applauds Parliament's decision to protect public health, not industry's interests
2002 Aug 24
http://www.haiweb.org/campaign/DTCA/pressreleaseEUrejectsDTCA.html
HSL2904
Bennett J, Collins J.
The relationship between physicians and the biomedical industries: advice from the Royal College of Physicians.
Clin Med 2002 Jul-Aug;2(4):320-2
Link to source with long URL
HSL2950
Perkin R.
Why the PAAB is important
Annals RCPSC 2001 Mar;34(2):105
HSL1032
Irwig LM, Loy CT, Chapman S, Glasziou PP, Mansfield PR, Salkeld GP, Walton MM.
!nform test kits distributed with the MJA.
Med J Aust 2000 May 15;172(10):518-9
HSL1221
Lexchin J.
Don't bite the hand that feeds you.
West J Med 1999 Oct;171(4):238-9
Link to source with long URL
HSL5516
McGhan WF.
Employer and consumer perspectives.
Value Health 1998 Nov 01;1(4):237-42
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1524-4733.1998.140237.x
HSL1829
Mansfield PR.
MaLAM, a medical lobby for appropriate marketing of pharmaceuticals.
Med J Aust 1997 Dec 1-15;167(11-12):590-2
http://www.mja.com.au/public/issues/xmas/mansfield/mansfield.html
HSL731
Desjardins JG.
The PMAC code of marketing practices: time for improvement? Pharmaceutical Manufacturers Association of Canada
CMAJ 1997 Feb 01;156(3):363-4
HSL5947
Orlowski JP, Vinicky JK, Edwards SS.
Conflicts of interest, conflicting interests, and interesting conflicts, Part 3.
J Clin Ethics 1996 Sum 01;7(2):184-6
HSL817
Toal CB, Borkowski KR.
The pharmaceutical industry, the Canadian Society for Clinical Pharmacology and academe: a partnership in health care
Can J Clin Pharmacol 1995;2(2):49
HSL6729
Mansfield PR.
MaLAM: encouraging trustworthy drug promotion
Essential Drugs Monitor 1994(17):6
HSL6255
Re: the promotion of Septrin (co-trimoxazole)
1993 Oct
HSL2141
Ranwella S.
Sri Lankan students campaign for rational medicine: the story of SIRHA.
Essent Drugs Monit 1993(16):10
HSL4988
Chetley A.
Promoting health or pushing drugs?
HAI News 1992 Oct(67):1-2, 10-12
HSL4970
Re: the promotion of chloramphenicol/streptomycin and Benadryl Expectorant and Humagel
1992 May
HSL4647
Chepesiuk R.
CE sponsorship
Drug Merchandising 1991;72(6):7
HSL4656
Fevang L.
CPhA replies
Drug Merchandising 1991;72(6):7, 9
HSL4681
Mansfield PR.
Encouraging drug companies to be honest
Australian Prescriber 1991;14:74
HSL4516
Bushe CJ.
Ethical guidelines for promotion of prescription drugs to physicians
New England Journal of Medicine 1990;322:65
HSL4447
Randall H.
Drug promotional problems
Medical Journal of Australia 1989;150:743
HSL3984
International drug marketing code
Lancet 1988;1:988
HSL4000
Harvey K.
The influence of advertising over prescribing
Australian Journal of Hospital Pharmacy 1988;18(3):25-28
HSL3888
Hilton D.
Promotion by the drug companies--should we accept their bribes?
J R Coll Gen Pract 1987 Jun;37(299):270
HSL3899
Laurence DR.
The academic clinical pharmacologist and the Royal College of Physicians Report on the relationship between physicians and the pharmaceutical industry.
Br J Clin Pharmacol 1987 Mar;23(3):253-5
HSL3938
MLAM letter follow up—Scanpharm
1987 Feb:2
HSL3925
Wall DW.
Ethics and the pharmaceutical industry: some ideas for general practitioners
Journal of the Royal College of General Practitioners 1987;37:267-269
HSL3822
Smith R.
Doctors and the drug industry: too close for comfort.
Br Med J (Clin Res Ed) 1986 Oct 11;293(6552):905-6
HSL3745
Gould D.
Funds that can foster suspicion
New Scientist 1985 Jun 13;106:30
HSL3742
Re: the promotion of pizotifen
1985 Jun 01
HSL3743
Mansfield PR.
Protecting the innocent from harm: the Medical Lobby for Appropriate Marketing (MLAM)
New Doctor 1985 Jun(36):22-24
HSL3692
Re: the promotion of Binotal
1984 Dec 01
HSL3636
Statement on ethical conduct in research by the Infectious Diseases Society of America.
J Infect Dis. 1984 Nov 01;150(5):792-3
HSL3677
Re: the promotion of Lomotil
1984 May 01
HSL3678
Donald AG.
Doctors and the pharmaceutical industry
Journal of the Royal College of General Practitioners 1984 May;34:301
HSL3624
Collier J.
The Medicines Act and the ABPI code.
Lancet 1984 Mar 24;1(8378):682-3
HSL3629
Cox P.
Rules of conduct and the pharmaceutical industry.
Lancet 1984 Mar 3;1(8375):517
HSL3616
MLAM
Lancet 1984;2:861
HSL3640
Lexchin J.
Reader upset at CFPC’s involvement in prescribing survey
Canadian Family Physician 1984;30:1454
HSL3643
Massam ADW.
Misleading advertisements
Lancet 1984;2:1159
HSL3653
Rice DI.
The CFPC’s executive director replies
Canadian Family Physician 1984;30:1454-1455
HSL3608
Re: the promotion of products containing amidopyrine
1983 Nov
HSL3592
Phillips I.
Supplements
Journal of Antimicrobial Chemotherapy 1983;12:199-200
HSL3531
Drugs and the Third World
Lancet 1982;2:1351
HSL3495
Journal IN.
Lancet 1981;2:801
HSL3399
Martin RW.
Drug advertisements
New Zealand Medical Journal 1978;87:295
HSL3303
Hargraves R.
Introduction
Journal of Drug Issues 1976;6:1-5
HSL3257
Barclay WR.
The American Medical Association's policy on drug advertising
Journal of Drug Issues 1974;4:287-290
HSL3266
Warnke P, O'Keefe D, Kiev A.
The Proprietary Association replies to the critics
Journal of Drug Issues 1974;4:217-222